Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 409 clinical trials
featured
Sternal Cerclage (sternal bone closure after open heart surgery)

The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle).

revascularisation
coronary revascularization
acute coronary syndrome
  • 1169 views
  • 05 Feb, 2021
  • 1 location
Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention

This study is to establish the primary hypothesis that Optical coherence tomography-guided Percutaneous coronary intervention(OCT-guided PCI) is non-inferior to Intravascular ultrasound-guided

  • 0 views
  • 25 Jan, 2021
  • 3 locations
Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention

Radial artery is the recommended route for percutaneous coronary intervention for it significantly reduces net adverse clinical events compared to the femoral approach. The success of the radial

  • 0 views
  • 02 Jul, 2021
  • 1 location
The OPTIMAL Randomized Controlled Trial

qualitative angio(QCA)-guided Percutaneous Coronary Intervention (PCI). Patients will be consented prior to the PCI procedure and then followed up to 2 years after the index procedure. Patients will

  • 0 views
  • 27 Jan, 2021
  • 30 locations
Ticagrelor De-escalation Strategy in East Asian Patients With AMI

more incidence of bleedings than pro-drug P2Y12 receptor inhibitor during chronic phase for management of acute myocardial infarction (AMI) following percutaneous coronary intervention (PCI). Also

  • 0 views
  • 23 Feb, 2021
  • 1 location
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)

revascularisation (PCI or CABG). ICD implantation after 40 days according to current guidelines (LVEF30%, or 35% with New York Heart Association (NYHA) class II/III symptoms) could be considered, if part of local

  • 113 views
  • 23 Jan, 2021
  • 36 locations
FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

The aim of the study is to compare clinical outcomes following fractional flow reserve (FFR)-guided versus angiography only guided strategy in treatment of non-infarction related artery (non-IRA) stenosis in patients with acute myocardial infarction (AMI) with multivessel disease Prospective, open-label, randomized, multicenter trial to test the clinical outcomes following FFR-guided …

stenosis
q waves
angiography
ischemia
bundle branch block
  • 0 views
  • 22 Sep, 2021
  • 2 locations
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

Coronary angiography is performed to evaluate for obstructive coronary artery disease. This is commonly performed via the transfemoral or transradial approach with the latter increasing in frequency. One of the most common complications of transradial access is radial artery occlusion occurring in ~5% of patients which prohibits the use of …

  • 11 views
  • 26 Jan, 2021
  • 1 location
China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome

In summary, the CHILLAS study will be the first multicenter study performed in a Chinese population using a patient-level analysis to compare the effects and safety of intensive statin therapy with that of moderate statin therapy. Therefore, it will determine whether "lower is better", that is, whether LDL cholesterol lowering …

hmg-coa reductase inhibitor
atorvastatin
intravascular ultrasound
cardiac event
low density lipoprotein
  • 0 views
  • 07 Nov, 2020
  • 1 location
Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Cardiogenic shock (CGS) affects up to 10% of patients suffering acute coronary syndrome. It has a 30 day mortality of 45-50%. No pharmacological nor intervention/device trials have had any impact on this mortality in the last 20 years. The EURO SHOCK Trial (supported by the European Union Horizons 2020 programme) …

  • 0 views
  • 12 May, 2021
  • 47 locations